Trichloroethylene and Parkinson’s disease: dissolving the puzzle

References

• Thaler A, Ash E, Gan-Or Z, Orr-Urtreger A, Giladi N. The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews. J. Neural Transm.116(11), 1473–1482 (2009).
   Google Scholar
• Latourelle JC, Sun M, Lew MF et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson’s disease: the GenePD study. BMC Med.6, 32 (2008).
   Google Scholar
• Clark LN, Wang Y, Karlins E et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology67(10), 1786–1791 (2006).
   PubMed Web of Science ®Google Scholar
• Ozelius LJ, Senthil G, Saunders-Pullman R et al.LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N. Engl. J. Med.354(4), 424–425 (2006).
   PubMed Web of Science ®Google Scholar
• Tanner CM, Ottman R, Goldman SM et al. Parkinson disease in twins. An etiologic study. JAMA281(4), 341–346 (1999).
   PubMed Web of Science ®Google Scholar
• Wirdefeldt K, Gatz M, Schalling M, Pedersen NL. No evidence for heritability of Parkinson disease in Swedish twins. Neurology63(2), 305–311 (2004).
   PubMed Web of Science ®Google Scholar
• Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Parkinsonism in Ontario: increased mortality compared with controls in a large cohort study. Neurology57(12), 2278–2282 (2001).
   Google Scholar
• Wermuth L, Bech S, Petersen MS et al. Prevalence and incidence of Parkinson’s disease in The Faroe Islands. Acta Neurol. Scand.118(2), 126–131 (2008).
   Google Scholar
• Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson’s disease in China. Coordinational Group of Neuroepidemiology, PLA. Chin. Med. J.104(11), 960–964 (1991).
   PubMedGoogle Scholar
• Zhang ZX, Roman GC, Hong Z et al. Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet365(9459), 595–597 (2005).
   PubMed Web of Science ®Google Scholar
• Bronstein J, Carvey P, Chen H et al. Meeting report: consensus statement-Parkinson’s disease and the environment: collaborative on health and the environment and Parkinson’s Action Network (CHE PAN) conference 26–28 June 2007. Environ. Health Perspect.117(1), 117–121 (2009).
   Google Scholar
• Guggenheim MA, Couch JR, Weinberg W. Motor dysfunction as a permanent complication of methanol ingestion. Presentation of a case with a beneficial response to levodopa treatment. Arch. Neurol.24(6), 550–554 (1971).
   PubMed Web of Science ®Google Scholar
• Pezzoli G, Barbieri S, Ferrante C, Zecchinelli A, Foà V. Parkinsonism due to n-hexane exposure. Lancet.2(8667), 874 (1989).
   Google Scholar
• McCrank E, Rabheru K. Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can. J. Psychiatry.34(9), 934–936 (1989).
   Google Scholar
• Tetrud JW, Langston JW, Irwin I, Snow B. Parkinsonism caused by petroleum waste ingestion. Neurology44(6), 1051–1054 (1994).
   PubMed Web of Science ®Google Scholar
• Uitti RJ, Snow BJ, Shinotoh H et al. Parkinsonism induced by solvent abuse. Ann. Neurol.35(5), 616–619 (1994).
   PubMed Web of Science ®Google Scholar
• Hertzman C, Wiens M, Snow B, Kelly S, Calne D. A case–control study of Parkinson’s disease in a horticultural region of British Columbia. Mov. Disord.9(1), 69–75 (1994).
   PubMed Web of Science ®Google Scholar
• Pals P, Van Everbroeck B, Grubben B et al. Case–control study of environmental risk factors for Parkinson’s disease in Belgium. Eur. J. Epidemiol.18(12), 1133–1142 (2003).
   Google Scholar
• McDonnell L, Maginnis C, Lewis S et al. Occupational exposure to solvents and metals and Parkinson’s disease. Neurology61(5), 716–717 (2003).
   Google Scholar
• Tanner CM, Ross GW, Jewell SA et al. Occupation and risk of parkinsonism: a multicenter case–control study. Arch. Neurol.66(9), 1106–1113 (2009).
   PubMed Web of Science ®Google Scholar
• Dick S, Semple S, Dick F, Seaton A. Occupational titles as risk factors for Parkinson’s disease. Occup. Med. (Lond.)57(1), 50–56 (2007).
   Google Scholar
• Seidler A, Hellenbrand W, Robra BP et al. Possible environmental, occupational, and other etiologic factors for Parkinson’s disease: a case–control study in Germany. Neurology46(5), 1275–1284 (1996).
   PubMed Web of Science ®Google Scholar
• Firestone JA, Lundin JI, Powers KM et al. Occupational factors and risk of Parkinson’s disease: a population-based case–control study. Am. J. Ind. Med.53(3), 217–223 (2010).
   PubMed Web of Science ®Google Scholar
• Lam HR, Ostergaard G, Ladefoged O. Three weeks’ and six months’ exposure to aromatic white spirit affect synaptosomal neurochemistry in rats. Toxicol. Lett.80(1–3), 39–48 (1995).
   PubMed Web of Science ®Google Scholar
• Mattia CJ, Ali SF, Bondy SC. Toluene-induced oxidative stress in several brain regions and other organs. Mol. Chem. Neuropathol.18(3), 313–328 (1993).
   PubMedGoogle Scholar
• Gash DM, Rutland K, Hudson NL et al. Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann. Neurol.63(2), 184–192 (2008).
   Google Scholar
• Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C. Trichloroethylene and parkinsonism: a human and experimental observation. Eur. J. Neurol.6(5), 609–611 (1999).
   Google Scholar
• Kochen W, Kohlmuller D, De Biasi P, Ramsay R. The endogeneous formation of highly chlorinated tetrahydro-β-carbolines as a possible causative mechanism in idiopathic Parkinson’s disease. Adv. Exp. Med. Biol.527, 253–263 (2003).
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Agency for Research on Cancer (IARC): Monographs on the Evaluation of Carcinogenic Risks to Humans (Volume 63). WHO, Geneva, Switzerland (1997).
   Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Trichloroethylene. United States Department of Health and Human Services, Atlanta, GA, USA (1997).
   Google Scholar
• Wu C, Schaum J. Exposure assessment of trichloroethylene. Environ. Health Perspect.108(Suppl. 2), 359–363 (2000).
   PubMed Web of Science ®Google Scholar
• Goldman SM, Tanner CM, Meng C et al. Parkinson’s disease risk is increased in discordant twins exposed to specific solvents. Presented at: The American Academy of Neurology Annual Meeting. Toronto, ON, Canada, 10–17 April 2010.
   Google Scholar
• Liu M, Choi DY, Hunter RL et al. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J. Neurochem.112(3), 773–783 (2010).
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging24(2), 197–211 (2003).
   PubMed Web of Science ®Google Scholar
• Di Monte DA. Mitochondrial DNA and Parkinson’s disease. Neurology41(5 Suppl. 2), 38–42 (1991).
   Google Scholar